Disclosed are novel inhibitors of Chk-1 and methods of using the same for therapy.
L'invention concerne de nouveaux inhibiteurs de Chk-1 et des méthodes d'utilisation de ces derniers en thérapie.




Download Full PDF Version (Non-Commercial Use)

Patent Citations (3)

    Publication numberPublication dateAssigneeTitle
    WO-0127116-A2April 19, 2001Eli Lilly And CompanyCondensed dihydroquinolinone derivatives for inhibiting mrp1
    WO-0146199-A1June 28, 2001Eli Lilly And CompanyMethodes et composes destines a inhiber mrp1
    WO-2005028474-A2March 31, 2005Millennium Pharmaceuticals, Inc.Pyrazoloquinoline derivatives as chk-1 inhibitors

NO-Patent Citations (2)

    BIPUL BARUAH ET AL.: "1,2-Diaryl-1-ethanone and pyrazolo[4,3-cÜquinoline-4-one as novel selective cyclooxygenase-2-inhibitors" BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 14, no. 2, January 2004 (2004-01), pages 445-448, XP002351193
    EL-HOSSAIN ALI MOHAMED ET AL.: "Synthesis and behaviour of 2,4-dichloro-6-methylquinoline and 4-chloro-6-methyl-2(1H)quinolone towards some nucleophilic reagents" J. SERB. CHEM. SOC., vol. 58, no. 10, 1993, pages 737-743, XP009056091

Cited By (1)

    Publication numberPublication dateAssigneeTitle
    WO-2017046603-A1March 23, 2017Redx Pharma PlcAntibacterial compounds and new uses thereof